SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000133
Filing Date
2024-03-05
Accepted
2024-03-05 17:14:23
Documents
94
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nwbo-20231231x10k.htm   iXBRL 10-K 3316720
2 EX-10.89 nwbo-20231231xex10d89.htm EX-10.89 65461
3 EX-10.90 nwbo-20231231xex10d90.htm EX-10.90 130827
4 EX-23.1 nwbo-20231231xex23d1.htm EX-23.1 3052
5 EX-31.1 nwbo-20231231xex31d1.htm EX-31.1 14289
6 EX-32.1 nwbo-20231231xex32d1.htm EX-32.1 7122
7 GRAPHIC nwbo-20231231x10k001.jpg GRAPHIC 88976
  Complete submission text file 0001410578-24-000133.txt   16526160

Data Files

Seq Description Document Type Size
8 EX-101.SCH nwbo-20231231.xsd EX-101.SCH 103504
9 EX-101.CAL nwbo-20231231_cal.xml EX-101.CAL 71178
10 EX-101.DEF nwbo-20231231_def.xml EX-101.DEF 501994
11 EX-101.LAB nwbo-20231231_lab.xml EX-101.LAB 711897
12 EX-101.PRE nwbo-20231231_pre.xml EX-101.PRE 700907
96 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20231231x10k_htm.xml XML 3603831
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 24722237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)